. . . . . . . . . . . . "[In each case, however, the neoplastic glands with no or few ISTR-labeled nuclei tended to express BCL-2 intensely, and all lesions of adenoma or carcinoma with more than 15% of ISTR-labeling indices showed weak BCL-2 immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:37:44+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .